ESC 365 - Benefit of optimal medical therapy in patients with polyvascular disease undergoing drug-eluting stent implantation

ESC Premium Access

Benefit of optimal medical therapy in patients with polyvascular disease undergoing drug-eluting stent implantation

Session: Poster session 5 - PCI - Adjunctive drug therapy

Topic: PCI - Adjunctive drug therapy

Speaker: Doctor R. Iijima (Tokyo, JP)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Raisuke Iijima

Toho University, Tokyo (Japan)

0 follower

13 more presentations in this session

High-dose statin pretreatment decreases cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: a meta-analysis of eighteenrandomized controlled trials

Speaker: Associate Professor B. Zheng (Beijing, CN)

Dual therapy versus Triple therapy in patients undergoing coronary stent implantation: a systematic review and meta-analysis

Speaker: Doctor S. Cornara (Savona, IT)

Prolonged dual antiplatelet therapy did not affect survival after left main artery stenting (Hong Kong Left Main Stenting Registry)

Speaker: Doctor C. Cheung (Hong Kong, HK)

Trimetazidine modified release therapy in post-myocardial infarction patients with multivessel disease having undergone incomplete revascularization: results of two years of follow up

Speaker: Professor Y. Lopatin (Volgograd, RU)

Effects of Clopidogrel and proton pump inhibitors on cardiovascular events in patients with type 2 diabetes mellitus after bare metal stent implantation: a nationwide cohort study

Speaker: Doctor C. Chen (Taipei, TW)

Access the full session

Poster session 5 - PCI - Adjunctive drug therapy

Speakers: Doctor R. Iijima, Associate Professor B. Zheng, Doctor S. Cornara, Doctor C. Cheung, Professor Y. Lopatin...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources